10 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
24900744	39	Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug Discovery.	Sanofi-Aventis
19217790	68	Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes.	Matrix Laboratories
17331715	19	Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors.	Korea Research Institute of Chemical Technology
15357972	30	Synthesis and DP-IV inhibition of cyano-pyrazoline derivatives as potent anti-diabetic agents.	Korea Research Institute of Chemical Technology
15115400	22	Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitors.	Pharmaceutical Research Institute
19643608	58	Novel N-substituted 4-hydrazino piperidine derivative as a dipeptidyl peptidase IV inhibitor.	Torrent Pharmaceuticals
18068977	3	Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin.	St. John'S University
29609120	44	Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.	Chinese Academy of Sciences
19645480	24	Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Protease.	Purdue University
19464884	34	Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole blood.	Wyeth Research